The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) is soliciting development and deployment of MAGPIX-based immunoassays which will comprise part of an orthogonal detection system supporting the current Ebola outbreak, as well as other DoD pathogen detection requirements.
Critical detection reagents are sought for the development of immunoassays including: Ebolavirus (EBOV), Lassa fever virus (LASV), Marburg virus (MARV), chikungunya virus, (CHKV), Crimean Congo hemorrhagic fever virus (CCHF), and the Eastern, Western, and Venezuelan equine encephalitis viruses (VEE, WEE and EEE).
While the first period will be devoted to the production of proteins from LASV and the Zaire strain of the Ebola virus (ZEBOV) based on USAMRIID’s current mission, option periods may include the same production or other appropriate targets as determined by USAMRIID’s mission.
The period of performance will be a one year base period with four option years.
Further details are available via Solicitation Number: W81XWH-15-R-0015. The response deadline is May 18, 2015.
